Microbot Medical receives first international regulatory approval for LIBERTY system in Israel

Microbot Medical announced that Israel's Ministry of Health AMAR Division approved marketing clearance for its LIBERTY Endovascular Robotic System, making Israel the second jurisdiction and first outside the U.S. to grant approval. The approval enables the company to obtain a Free Sale Certificate for additional jurisdictions and supports its commercialization strategy as it pursues CE Mark certification for EU expansion.